Roles of gender, obesity, and lifestyle-related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease

Hepatology Research

Volumn 42, Issue 4, 2012, Pages 359-367

  Taniai, Makiko ^a   Hashimoto, Etsuko ^a   Tokushige, Katsutoshi ^a   Kodama, Kazuhisa ^a   Kogiso, Tomomi ^a   Torii, Nobuyuki ^a   Shiratori, Keiko ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Alcoholic liver disease; Gender difference; Lifestyle related disease; Non alcoholic fatty liver disease; Psychological disorders

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ANXIETY DISORDER; ARTICLE; BIPOLAR DISORDER; BULIMIA; DEPRESSION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HUMAN; LIFESTYLE; LIVER CIRRHOSIS; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE;

EID: 84858803662     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00935.x     Document Type: Article

References (41)

1. Jimba S, Nakagami T, Takahashi M etal. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med 2005; 22: 1141-5.
2. Kojima S, Watanabe N, Numata M, Ogawa T, Matsuzaki S. Increase in the prevalence of fatty liver in Japan over the past 12years: analysis of clinical background. J Gastroenterol 2003; 38: 954-61.
3. Yamada T, Fukatsu M, Suzuki S, Yoshida T, Tokudome S, Joh T. Alcohol drinking may not be a major risk factor for fatty liver in Japanese undergoing a health checkup. Dig Dis Sci 2010; 55: 176-82.
4. Michitaka K, Nishiguchi S, Aoyagi Y etal. Etiology of liver cirrhosis in Japan: a nationwide survey. J Gastroenterol 2010; 45: 86-94.
5. Ikai I, Kudo M, Arii S etal. Report of the 18th follow-up survey of primary liver cancer in Japan. Hepatol Res 2010; 40: 1043-59.
6. Tokushige K, Hashimoto E, Horie Y, Taniai M, Higuchi S. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease and chronic liver disease of unknown etiology: report of the Nationwide Survey. J Gastroenterol 2011; 46: 1230-7.
7. Abe H, Yoshizawa K, Kitahara T, Aizawa R, Matsuoka M, Aizawa Y. Etiology of non-B non-C hepatocellular carcinoma in the eastern district of Tokyo. J Gastroenterol 2008; 43: 967-74.
8. Marcellin P, Pequignot F, Delarocque-Astagneau E etal. Mortality related to chronic hepatitis B and chronic hepatitis C in France: evidence for the role of HIV coinfection and alcohol consumption. J Hepatol 2008; 48: 200-7.
9. Otani K, Korenaga M, Beard MR etal. Hepatitis C virus core protein, cytochrome P450 2E1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005; 128: 96-107.
10. Hashimoto E, Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol 2011; 46 (Suppl 1): 63-9.
11. Dunn W, Xu R, Schwimmer JB. Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease. Hepatology 2008; 47: 1947-54.
12. Ekstedt M, Franzén LE, Holmqvist M etal. Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease. Scand J Gastroenterol 2009; 44: 366-74.
13. Dixon JB, Bhathal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001; 121: 91-100.
14. Suzuki A, Angulo P, St Sauver J, Muto A, Okada T, Lindor K. Light to moderate alcohol consumption is associated with lower frequency of hypertransaminasemia. Am J Gastroenterol 2007; 102: 1912-9.
15. Stepanova M, Rafiq N, Younossi ZM. Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study. Gut 2010; 59: 1410-15.
16. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25: 108-11.
17. Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995; 346: 987-90.
18. Sato N, Lindros KO, Baraona E etal. Sex difference in alcohol-related organ injury. Alcohol Clin Exp Res 2001; 25: 40S-5S.
19. Moshage H. Alcoholic liver disease: a matter of hormones? J Hepatol 2001; 35: 130-3.
20. Gramenzi A, Caputo F, Biselli M etal. Review article: alcoholic liver disease - pathophysiological aspects and risk factors. Aliment Pharmacol Ther 2006; 24: 1151-61.
21. Jörvelöinen HA, Lukkari TA, Heinaro S, Sippel H, Lindros KO. The antiestrogen toremifene protects against alcoholic liver injury in female rats. J Hepatol 2001; 35: 46-52.
22. Yatsuji S, Hashimoto E, Tobari M, Taniai M, Tokushige K, Shiratori K. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009; 24: 248-54.
23. Clark JM. The epidemiology of nonalcoholic fatty liver disease in adults. J Clin Gastroenterol 2006; 40 (Suppl 1): S5-10.
24. Suzuki A, Abdelmalek MF. Nonalcoholic fatty liver disease in women. Womens Health (Lond Engl) 2009; 5: 191-203.
25. Health and Welfare Statistics Association. Journal of Health and Welfare Statistics 2009; 56: 1-512. (in Japanese).
26. Ahima RS. Connecting obesity, aging and diabetes. Nat Med 2009; 15: 996-7.
27. Minamino T, Orimo M, Shimizu I etal. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009; 15: 1082-7.
28. Williams JR. The Declaration of Helsinki and public health. Bull World Health Organ 2008; 86: 650-2.
29. Takada A, Tsutsumi M. National survey of alcoholic liver disease in Japan (1968-91). J Gastroenterol Hepatol 1995; 10: 509-16.
30. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-63.
31. World Health Organization. Definition, Diagonosis, and Classification of Diabetes. Mellitus and It's Complications. Report of A WHO Consultation. Part I: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999.
32. Examination Committee of Criteria for Metabolic Syndrome in Japan. [Definition and diagnosis for metabolic syndrome.] J Jpn Soc Inter Med 2005; 94: 784-809. (in Japanese).
33. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53: 372-84.
34. Health and Welfare Statistics Association. [Patient Survey 2008 (All Japan): statistics and information department, minister's secretariat, ministry of health, labour and welfare.] 2008. (in Japanese).
35. Ewusi-Mensah I, Saunders JB, Johnson RD, Williams R. Alcohol dependence and psychopathology in alcoholic liver disease. Br J Addict 1986; 81: 231-5.
36. Bellentani S, Saccoccio G, Costa G etal. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997; 41: 845-50.
37. Savolainen VT, Liesto K, Männikkö A, Penttilä A, Karhunen PJ. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. Alcohol Clin Exp Res 1993; 17: 1112-17.
38. Becker U, Grønbaek M, Johansen D, Sørensen TI. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002; 35: 868-75.
39. Mendenhall C, Roselle GA, Gartside P, Moritz T. Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies. Alcohol Clin Exp Res 1995; 19: 635-41.
40. Mezey E. Dietary fat and alcoholic liver disease. Hepatology 1998; 28: 901-5.
41. Leevy CM, Moroianu SA. Nutritional aspects of alcoholic liver disease. Clin Liver Dis 2005; 9: 67-81.